InsidersTradesSigma
Track the Resverlogix Corp. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €34.4m. The latest transaction was reported on 9 July 2026 (56 - Grant of rights). Among the most active insiders: Cann, Aaron Bradley. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Resverlogix Corp. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades cardiovasculares y metabólicas. Cotiza en la XTSE.